Twin Tree Management
SAGE

Twin Tree Management’s Sage Therapeutics SAGE Stock Holding History

Twin Tree Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,300
Closed -$4.08M – 1480
2019
Q2 		$4.08M Sell
22,300
-47,300
-68% -$8.07M 0.02% 507
2019
Q1 		$11.1M Buy
69,600
+28,600
+70% +$4.14M 0.06% 274
2018
Q4 		$3.93M Buy
41,000
+1,000
+3% +$114K 0.02% 549
2018
Q3 		$5.65M Buy
40,000
+7,800
+24% +$1.2M 0.04% 369
2018
Q2 		$5.04M Buy
+32,200
New +$5.06M 0.03% 422

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Twin Tree Management's SAGE Position: Q1 2019 in Review

Twin Tree Management sold out of Sage Therapeutics (SAGE) in Q1 2019, closing a stake of 14,900 shares — an estimated $2.16M sold.

Twin Tree Management first reported a position in SAGE in Q1 2018 and held it in 4 quarters. The position peaked at $1.43M in Q4 2018. 268 funds tracked by Wall St. Rank hold SAGE as of Q1 2019.

  • Twin Tree Management reported no remaining Sage Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Twin Tree Management sold 14,900 Sage Therapeutics shares in Q1 2019, an estimated $2.16M.
  • Twin Tree Management first reported a position in Sage Therapeutics in Q1 2018 and held it in 4 quarters.
  • Twin Tree Management's Sage Therapeutics position peaked at $1.43M in Q4 2018.
  • 268 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2019.

Based on Twin Tree Management's 13F filing for Q1 2019, filed 10 May 2019.